Safety of BRAF+MEK Inhibitor Combinations: Severe Adverse Event Evaluation by Tomer Meirson, Nethanel Asher, David Bomze, Gal Markel

Get full text

Normal Modes Expose Active Sites in Enzymes. by Yitav Glantz-Gashai, Tomer Meirson, Abraham O Samson

Get full text

Immunotherapy Discontinuation in Metastatic Melanoma: Lessons from Real-Life Clinical Experience by Nethanel Asher, Noa Israeli-Weller, Ronnie Shapira-Frommer, Guy Ben-Betzalel, Jacob Schachter, Tomer Meirson, Gal Markel

Get full text

Real World Outcomes of Ipilimumab and Nivolumab in Patients with Metastatic Melanoma by Nethanel Asher, Guy Ben-Betzalel, Shaked Lev-Ari, Ronnie Shapira-Frommer, Yael Steinberg-Silman, Neta Gochman, Jacob Schachter, Tomer Meirson, Gal Markel

Get full text

Trends in Women’s Leadership of Oncology Clinical Trials by Ithai Waldhorn, Ayelet Dekel, Anna Morozov, Elisa Sardas Alon, Danielle Stave, Noam Ben Tsrooya, Shir Schlosser, Gal Markel, Gal Markel, David Bomze, Tomer Meirson

Get full text

Analysis of new treatments proposed for malignant pleural mesothelioma raises concerns about the conduction of clinical trials in oncology by Tomer Meirson, Valerio Nardone, Francesca Pentimalli, Gal Markel, David Bomze, Maria D’Apolito, Pierpaolo Correale, Antonio Giordano, Luigi Pirtoli, Camillo Porta, Steven G Gray, Luciano Mutti

Get full text

Comparison of non-myeloablative lymphodepleting preconditioning regimens in patients undergoing adoptive T cell therapy by Ronnie Shapira-Frommer, Elad Jacoby, Orit Itzhaki, Abraham Nissani, Gal Markel, Jacob Schachter, Shaked Lev-Ari, Tomer Meirson, Nethanel Asher, Guy Ben-Betzalel, Michal J. Besser

Get full text

Hepatitis C Virus Enhances the Invasiveness of Hepatocellular Carcinoma via EGFR-Mediated Invadopodia Formation and Activation by Liat Ninio, Abraham Nissani, Tomer Meirson, Tom Domovitz, Alessandro Genna, Shams Twafra, Kolluru D. Srikanth, Roba Dabour, Erez Avraham, Ateret Davidovich, Hava Gil-Henn, Meital Gal-Tanamy

Get full text

HCV Infection Increases the Expression of ACE2 Receptor, Leading to Enhanced Entry of Both HCV and SARS-CoV-2 into Hepatocytes and a Coinfection State by Tom Domovitz, Samer Ayoub, Michal Werbner, Joel Alter, Lee Izhaki Tavor, Yfat Yahalom-Ronen, Evgeny Tikhonov, Tomer Meirson, Yaakov Maman, Nir Paran, Tomer Israely, Moshe Dessau, Meital Gal-Tanamy

Get full text

Hepatitis C virus leaves an epigenetic signature post cure of infection by direct-acting antivirals. by Shira Perez, Antony Kaspi, Tom Domovitz, Ateret Davidovich, Anat Lavi-Itzkovitz, Tomer Meirson, Jacinta Alison Holmes, Chia-Yen Dai, Chung-Feng Huang, Raymond T Chung, Assy Nimer, Assam El-Osta, Gur Yaari, Salomon M Stemmer, Ming-Lung Yu, Izhak Haviv, Meital Gal-Tanamy

Get full text